Botanix Pharmaceuticals Limited
BXPHF
$0.04
$0.0010.88%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.25% | -4.94% | -542.17% | -530.15% | -464.91% |
| Total Depreciation and Amortization | 6.86% | 3.60% | 1,639.34% | 1,603.32% | 13,392.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 321.25% | 314.48% | 671.09% | 656.63% | -146.59% |
| Change in Net Operating Assets | -- | -- | -1,633.68% | -1,605.10% | -- |
| Cash from Operations | 0.24% | 3.29% | -969.00% | -949.01% | -712.66% |
| Capital Expenditure | 97.63% | 97.69% | -148.81% | -143.65% | -150.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 42.02% | 43.82% | 100.00% | 100.00% | 94.82% |
| Cash from Investing | 47.92% | 49.49% | 94.10% | 94.21% | 94.22% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -234.42% | -234.42% | -- | -- | -- |
| Issuance of Common Stock | -95.45% | -95.45% | -44.84% | -44.84% | -98.37% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 20.82% | 20.82% | -- |
| Cash from Financing | -742.45% | -723.27% | -7.60% | -9.33% | -98.50% |
| Foreign Exchange rate Adjustments | -160.98% | -159.13% | -182.73% | -181.09% | 190.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.82% | -5.50% | -73.66% | -74.15% | -482.83% |